Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyteplatelet aggregate formation: Stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers

Platelets

Volumn 23, Issue 5, 2012, Pages 368-375

  Patko, Zsofia ^a   Csaszar, Albert ^b   Acsady, Gyorgy ^a   Peter, Karlheinz ^c   Schwarz, Meike ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL MEDICAL CENTER   (Hungary)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

CD40L; Glycoprotein IIb IIIa; Leukocytes; Mac 1 adhesive receptor; Platelets

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE AGGREGATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

ANIMALS; BLOOD PLATELETS; CHO CELLS; CRICETINAE; HUMANS; LEUKOCYTES; MACROPHAGE-1 ANTIGEN; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TRANSFECTION;

CRICETULUS GRISEUS;

EID: 84863658915     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.625098     Document Type: Article

References (46)

1. Todd RF. The continuing saga of complement receptor type 3 (CR3). J Clin Invest 1996;98:1-2.
2. Ross G, Lambris J. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. J Exp Med 1982; 55:96-110.
3. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991;65:961-971.
4. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EF. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/Cd18). J Biol Chem 1990;265:12119-12122.
5. Konstantopoulos K, Neelamegham S, Burns AR, Hentzen E, Kansas GS, Snapp KR, Berg EL, Hellums JD, Smith CW, McIntire LV, et al. Venous levels of shear support neutrophilplatelet adhesion and neutrophil aggregation in blood via P-selectin and b2-integrin. Circulation 1998;98:873-882.
6. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537.
7. Stahl AL, Sartz L, Nelsson A, Bekassy ZD, Karpman D. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 2009;4:e6990.
8. Tamagawa-Mineoka R, Katoh N, Ueda E, Takenaka H, Kita M, Kishimoto S. The role of platelets in leukocyte recruitment in chronic contact hypersensitivity induced by repeated elicitation. Am J Pathol 2007;170:2019-2029.
9. Sampson MJ, Davies IR, Brown JC, Ivory K, Hughes DA. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 2002;22:1187-1193.
10. Vaidyula VR, Boden G, Rao AK. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 2006;17:577-585.
11. Weiss DJ, Evanson OA, McClenahan D, Fagliari J, Walcheck B. Shear-induced platelet activation and plateletneutrophil aggregate formation by equine platelets. Am J Vet Res 1998;59:1243-1246.
12. Tandon P, Diamond SL. Kinetics of beta2-integrin and Lselectin bonding during neutrophil aggregation in shear flow. Biophys J 1998;75:3163-3178.
13. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352-358.
14. Patel PB, Pfau SE, Cleman MW, Brennan JJ, Howes C, Remetz M, Cabin HS, Setaro JF, Rinder HM. Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. Am J Cardiol 004;93:410-413.
15. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002-1006.
16. Arefieva TI, Provatorov SI, Samko AN, Krasnikova TL, Resink TJ, Erne P, Tkachuk VA, Chazov EI. Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol 2001;28:804-808.
17. Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke 2003;34:2560-2567.
18. Steiner S, Seidinger D, Huber K, Kaun C, Minar E, Kopp CW. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression. Arterioscler Thromb Vasc Biol 2003; 23:1697-1702.
19. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004; 125:777-787.
20. Cao YJ, Wang YM, Zhang J, Zeng YJ, Liu CF. The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction. J Thromb Thrombolysis 2009;27:233-238.
21. Marquardt L, Anders C, Buggle F, Palm F, Hellstern P, Grau AJ. Leukocyte-platelet aggregates in acute and subacute ischemic stroke. Cerebrovasc Dis 2009;28:276-282.
22. Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M. The possible association of in vivo leukocyteplatelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets 2004;12:419-422.
23. Harding SA, Sommerfield AJ, Sarma J, Twomey PJ, Newby DE, Frier BM, Fox KA. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 2004;176:321-325.
24. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, et al. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 2007;115:1571-1580.
25. Brown KK, Henson PM, Maclouf J, Moyle M, Ely JA, Worthen GS. Neutrophil-platelet adhesion: Relative roles of platelet P-selectin and neutrophil beta2 (DC18) integrins. Am J Respir Cell Mol Biol 1998;18:100-110.
26. Spangenberg P, Redlich H, Bergmann I, Lösche W, Götzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993;70:514-521.
27. Jy W, Mao WW, Horstman L, Tao J, Ahn YS. Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995;21:217-231.
28. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
29. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
30. Freedman JE. CD40-CD40L and platelet function. Circ Res 2003;92:944-946.
31. Henn V, Steinbach S, Büchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001;98:1047-1054.
32. Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC, Wijnands E, Goossens P, van Kruchten R, Thevissen L, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 2010; 116:4317-4327.
33. Peter K, Toole TE. Modulation of cell adhesion by changes in-L-2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J Exp Med 1995;181:315-326.
34. Toole TE, Katagiri Y, Fauli RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994;124:1047-1059.
35. Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 2002;8:247-252.
36. Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Nat Acad Sci USA 2003;100:12367-12371.
37. Hagemeyer CE, Peter K. Targeting the platelet integrin GPIIb/IIIa. Curr Pharm Des 2010;16:4119-4133.
38. Lippi G, Montagnana M, Danese E, Favaloro EJ, Franchini M. Glycoprotein IIb/IIIa inhibitors: An update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Biomark Med 2011;5:63-70.
39. Field EJ, MacLeod I. Platelet adherence to polymorphs. Br Med J 1963;2:388-389.
40. Crome PE, Barkhan P. Platelet adherence to polymorphs. Br Med J 1963;2:871.
41. Hentzen ER, Neelamegham S, Kansas GS, Benanti JA, McIntire LV, Smith CW, Simon SI. Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. Blood 2000;95:911-920.
42. Neelamegham S, Taylor AD, Shankaran H, Smith CW, Simon SI. Shear and time-dependent changes in Mac-1, LFA- 1, and ICAM-3 binding regulate neutrophil homotypic adhesion. J Immunol 2000;164:3798-3805.
43. Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, Kubes P. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 1997;99:2782-2790.
44. Stacker SA, Springer TA. Leukocyte integrin P150,95 (CD11c/CD18) functions as an adhesion molecule binding to a counter-receptor on stimulated endothelium. J Immunol 1991;146:648-655.
45. Gaboury JP, Kubes P. Reductions in physiologic shear rates lead to CD11/CD18-dependent, selectin-independent leukocyte rolling in vivo. Blood 1994;83:345-350.
46. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-1769.